- Home
- STTK vs RGS Comparison
STTK vs RGS Comparison
Compare STTK & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- RGS
- Stock Information
- Founded
- STTK 2016
- RGS 1922
- Country
- STTK United States
- RGS United States
- Employees
- STTK N/A
- RGS N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- RGS Other Consumer Services
- Sector
- STTK Health Care
- RGS Consumer Discretionary
- Exchange
- STTK Nasdaq
- RGS Nasdaq
- Market Cap
- STTK 54.4M
- RGS 53.4M
- IPO Year
- STTK 2020
- RGS 1991
- Fundamental
- Price
- STTK $1.16
- RGS $22.05
- Analyst Decision
- STTK Hold
- RGS
- Analyst Count
- STTK 3
- RGS 0
- Target Price
- STTK $2.00
- RGS N/A
- AVG Volume (30 Days)
- STTK 332.9K
- RGS 41.7K
- Earning Date
- STTK 11-14-2024
- RGS 01-29-2025
- Dividend Yield
- STTK N/A
- RGS N/A
- EPS Growth
- STTK N/A
- RGS N/A
- EPS
- STTK N/A
- RGS 37.55
- Revenue
- STTK $6,435,000.00
- RGS $195,670,000.00
- Revenue This Year
- STTK $313.04
- RGS N/A
- Revenue Next Year
- STTK N/A
- RGS N/A
- P/E Ratio
- STTK N/A
- RGS $0.66
- Revenue Growth
- STTK 382.75
- RGS N/A
- 52 Week Low
- STTK $0.94
- RGS $3.87
- 52 Week High
- STTK $11.76
- RGS $35.50
- Technical
- Relative Strength Index (RSI)
- STTK 44.02
- RGS 52.96
- Support Level
- STTK $1.07
- RGS $21.96
- Resistance Level
- STTK $1.38
- RGS $24.35
- Average True Range (ATR)
- STTK 0.12
- RGS 1.58
- MACD
- STTK 0.01
- RGS 0.01
- Stochastic Oscillator
- STTK 27.88
- RGS 43.11
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.